Kura Oncology, Inc. (KURA)
10.22
-0.24
(-2.29%)
USD |
NASDAQ |
Dec 12, 16:00
10.20
-0.02
(-0.15%)
After-Hours: 20:00
Kura Oncology EPS Diluted (Quarterly): -0.8456 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| AIM ImmunoTech, Inc. | -1.569 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -74.12M |
| Revenue (Quarterly) | 20.75M |
| Total Expenses (Quarterly) | 94.87M |
| Enterprise Value | 359.12M |
| Gross Profit Margin (Quarterly) | 99.21% |
| Profit Margin (Quarterly) | -357.2% |
| Earnings Yield | -24.25% |
| Normalized Earnings Yield | -24.25 |